Added to YB: 2025-07-22
Pitch date: 2025-07-19
FBIO [neutral]
Fortress Biotech, Inc.
-3.54%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally.
Market Cap
$67.7M
Pitch Price
$1.98
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.59
P/E
0.62
EV/Sales
-0.49
Sector
Biotechnology
Category
special_situation
Show full summary:
Fortress Biotech - Sold shares in FBIOP after CAEL-101 fails to reach primary endpoint in P3
FBIO (sell): Sold shares after CAEL-101 P3 failure, negative for FBIOP preferred stock as approval would've provided $19.6M for reinstated dividends in 2025-26. Increases pressure on CUTX-101 and its potential PRV as remaining lifeline.
Read full article (1 min)